A New Port in a Storm: Comparing the M&A Safe-Harbor Policy With Leniency
October 24, 2023, 1:59 PM
DOJ’s announcement of a safe harbor for voluntary self-disclosure in the context of acquisitions is the latest policy change in support of its effort to incentivize compliance, empower compliance professionals, and make compliance a cost-savings center.
It also heightens the importance of diligence and post-acquisition investigation to unearth acquired misconduct within the policy’s short, six-month window for self-disclosure.
While the policies have important similarities, how the M&A policy will interact with the Antitrust Division’s leniency policy raises more questions than answers because of certain differences in each policy’s requirements and benefits:
M&A Voluntary Disclosure | Antitrust Division Leniency Policy |
Requirements | |
| Application: Applies Department-wide to criminal conduct discovered in bona fide, arms-length M&A transactions. | Application: Applies to violations of Sections 1 and 3 of the Sherman Act. |
| Timing: Prompt disclosure, within a baseline of six months post-closing whether the conduct was discovered pre- or post-acquisition. Though companies cannot wait to disclose threats “involving ongoing or imminent harm.” | Timing: Prompt self-reporting upon discovery. |
| Disclosure: Does not apply to misconduct that was otherwise required to be disclosed or already public or known to the Department. | Disclosure: Only available to the first organization or individual to self-report. Type B leniency is available if the Division knows about the conduct but does not yet have evidence likely to result in a sustainable conviction against the applicant. |
| Cooperation: Acquiring companies must cooperate with the ensuing investigation. | Cooperation: Applicants must provide timely, truthful, continuing, and complete cooperation throughout the Antitrust Division’s investigation. |
Remediation: Companies must engage in timely and appropriate remediation, restitution, and disgorgement.
There is a baseline of one year from the date of closing to fully remediate the misconduct. | Remediation: Applicants must pay restitution, remediate the harm caused by the illegal activity, and improve their compliance program. Applicants must satisfy their compliance and remediation obligations and present concrete, reasonably achievable restitution plans to receive conditional leniency letter. |
Benefits | |
| Corporate charges: Presumption of a declination. | Corporate charges: Successful applicants face no criminal charges. |
| Individual liability: No non-prosecution protection for employees. | Individual liability: In the Type-A context, non-prosecution protection is available for cooperating, current employees. In the Type-B context, non-prosecution protection is available at the Division’s discretion. |
| Civil suits: No effect. | Civil suits: Single damages and no joint and several liability under ACPERA. |

To subscribe to our publications, click here.
News & Insights
News & Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
